Lantern Pharma Inc. ( LTRN) - Stock Earnings
LTRN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
LTRN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.2 million USD | — USD |
| 2025Q4 | -4.1 million USD | — USD |
| 2026Q1 | -3.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LTRN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | — USD |
| 2024 | -20.8 million USD | — USD |
| 2025 | -17.1 million USD | — USD |
| 2026 Est. | — | — |
LTRN
Price: $2.52
52 week price:
Earnings Per Share: -1.45 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2116
Market Capitalization: 33.9 million